Risk factors for post-operative wound infection in the setting of chorioamnionitis and cesarean delivery

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 29, Issue 10, 2016, Pages 1541-1545

  Dotters Katz, Sarah K ^a   Feldman, Chelsea ^b   Puechl, Allison ^b   Grotegut, Chad A ^b   Heine, R Phillips ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cesarean delivery; chorioamnionitis; ertapenem; wound infection

Indexed keywords

AMPICILLIN; CLINDAMYCIN; ERTAPENEM; GENTAMICIN;

ADULT; ARTICLE; BODY MASS; CESAREAN SECTION; CHORIOAMNIONITIS; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; INFECTION RISK; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL INFECTION; TOBACCO CONSUMPTION; ADVERSE EFFECTS; NORTH CAROLINA; PREGNANCY; SURGICAL WOUND INFECTION; YOUNG ADULT;

ADULT; CESAREAN SECTION; CHORIOAMNIONITIS; FEMALE; HUMANS; NORTH CAROLINA; PREGNANCY; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL WOUND INFECTION; YOUNG ADULT;

EID: 84958205894     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2015.1058773     Document Type: Article

References (19)

1. Gibbs RS, Duff P. Progress in pathogenesis and management of clinical intraamniotic infection. Am J Obstet Gynecol 1991; 164: 1317-26
2. Black LP, Hinson L, Duff P. Limited course of antibiotic treatment for chorioamnionitis. Obstet Gynecol 2012; 119: 1102-5
3. Turnquest MA, How HY, Cook CR, et al. Chorioamnionitis: is continuation of antibiotic therapy necessary after cesarean section? Am J Obstet Gynecol 1998; 179: 1261-6
4. Chapman SJ, Owen J. Randomized trial of single-dose versus multiple-dose cefotetan for the postpartum treatment of intrapartum chorioamnionitis. Am J Obstet Gynecol 1997; 177: 831-4
5. Edwards RK, Duff P. Single additional dose postpartum therapy for women with chorioamnionitis. Obstet Gynecol 2003; 102: 957-61
6. Beattie PG, Rings TR, Hunter MF, Lake Y. Risk factors for wound infection following caesarean section. Aust NZ J Obstet Gynaecol 1994; 34: 398-402
7. Gunatilake RP, Perlow JH. Obesity and pregnancy: clinical management of the obese gravida. Am J Obstet Gynecol 2011; 204: 106-19
8. Pelle H, Jepsen OB, Larsen SO, et al. Wound infection after cesarean section. Infect control 1986; 7: 456-61
9. Stamilio DM, Scifres CM. Extreme obesity and postcesarean maternal complications. Obstet Gynecol 2014; 124: 227-32
10. Vermillion ST, Lamoutte C, Soper DE, Verdeja A. Wound infection after cesarean: effect of subcutaneous tissue thickness. Obstet Gynecol 2000; 95: 923-6
11. Subramaniam A, Jauk VC, Figueroa D, et al. Risk factors for wound disruption following cesarean delivery. J Matern Fetal Neonatal Med 2014; 27: 1237-40
12. An MM, Zou Z, Shen H, et al. Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-Analysis of randomized controlled trials. BMC Infect Dis 2009; 9: 193
13. Solomkin JS, Yellin AE, Rotstein OD, et al. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial. Ann Surg 2003; 237: 235-45
14. Yellin AE, Hassett JM, Fernandez A, et al. Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-Abdominal infections in adults. Int J Antimicrob Agents 2002; 20: 165-73
15. Brown KR, Williams SF, Apuzzio JJ. Ertapenem compared to combination drug therapy for the treatment of postpartum endometritis after cesarean delivery. J Matern Fetal Neonatal Med 2012; 25: 743-6
16. Tita AT, Andrews WW. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol 2010; 37: 339-54
17. Nix DE, Majumdar AK, DiNubile MJ. Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians. J Antimicrob Chemother 2004; 53: ii23-8
18. Muller AE, Mouton JW, Oostvogel PM, et al. Pharmacokinetics of clindamycin in pregnant women in the peripartum period. Antimicrob Agents Chemother 2010; 54: 2175-81
19. Popovic J, Grujic Z, Sabo A. Influence of pregnancy on ceftriaxone, cefazolin and gentamicin pharmacokinetics in caesarean vs. non-pregnant sectioned women. J Clin Pharm Ther 2007; 32: 595-602